Recall
FDAHealthMarch 11, 2026

Fresenius Kabi USA, LLC — 5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit o

⚠️ Lack of Assurance of Sterility

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 11, 2026

US Nationwide , Alaska, and Puerto Rico.

What's affected?

Product
5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30.
Lot code
Batch# 6402165, Exp Date: 05/30/2028.

Additional details

Batch# 6402165, Exp Date: 05/30/2028.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.